October 31, 2024
The US Food and Drug Administration (FDA) has approved a 10-mg dose of Roxybond (Protega Pharmaceuticals), an opioid analgesic indicated for the management of severe pain in […]
October 31, 2024
Methadone has been shown to be highly effective for opioid use disorder (OUD). So why is it still so difficult to prescribe in the United States […]
October 30, 2024
[10/30/2024] The Food and Drug Administration is advising consumers not to purchase or use ITCHA XS, a product promoted and sold for weight loss on various […]
October 30, 2024
Abortion access, IVF, and other reproductive rights are focal points of the 2024 presidential race. On November 5, abortion access and reproductive rights will be top […]
October 30, 2024
For people with severe symptomatic hip osteoarthritis, total hip replacement (THR) alleviates hip pain and improves function much more effectively than a resistance training program supervised […]
October 30, 2024
Uptake of seasonal influenza and COVID-19 vaccination among risk groups such as older adults in many European Union/European Economic Area member states between 2023 and 2024 […]
October 30, 2024
[10/30/2024] FDA is warning consumers to not purchase or use Skin-Cap aerosol spray products because they may contain undisclosed steroids. This product, sold by Chemigroup France, […]
October 30, 2024
Quality Matters Related to Components of a Drug FDA continues to identify several issues related to repackagers of bulk drug substances, also called active pharmaceutical ingredients […]
October 30, 2024
FDA is reminding compounders to only produce sterile drugs using components that are suitable for compounding drugs intended to be sterile. The agency is aware of […]